Platelet Reactivity in Septic Shock

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

May 30, 2018

Study Completion Date

August 30, 2018

Conditions
Septic ShockThrombocytopeniaSepsisPlatelet AggregationDisseminated Intravascular Coagulation
Interventions
DIAGNOSTIC_TEST

platelet responsiveness evaluation

Blood samples were anticoagulated with 0.129 mmol/L of sodium citrate and then centrifugated for 10 min at 200 rpm; platelets aggregation was assessed with an AggRAM Advanced Modular System light transmittance aggregometer (Helena Laboratories, Beaumont, Texas, USA). Low-molecular-weight heparin (LMWH) was given at least 8 hours before any blood aggregation sample. Agonist used to initiate aggregation test were: -Adenosine diphosphate (ADP) to assess P2Y12-dependent platelet aggregation; (20 ng) - Arachidonic acid (AA) to assess cyclooxygenase-dependent platelet Adenosine diphosphate aggregation (1 mcg) - thrombin receptor-activating peptide-6 (TRAP-6) to assess protease-activated receptor 1-dependent platelet aggregation. Max aggregation reached (Aggmax), the slope of the curve (slope) and the latency time (lat) were analyzed for each agonist.

Trial Locations (1)

44121

Università di Ferrara, Ferrara

All Listed Sponsors
lead

Università degli Studi di Ferrara

OTHER

NCT03716310 - Platelet Reactivity in Septic Shock | Biotech Hunter | Biotech Hunter